More News! 18 Nov 2022
Triastek cleared for 3D printed medicine treatment of ulcerative colitis
Triastek, Inc. has received clearance for its Investigational New Drug (IND) application from the United States Food and Drug Administration…
Triastek
- Latest Posts
News and Trends 19 Aug 2022
Beyond Biotech podcast 10: Endpoint Health, Nevrargenics, Triastek
This week our guests on the podcast are Xianghao Zuo, deputy director of R&D at Triastek; Endpoint Health CEO Jason…
Best in Biotech 28 Jul 2022
Five companies personalizing treatments with 3D printed drugs
There has been a noticeable shift in recent years towards the personalization of medicine, with the pharmaceutical industry showing interest…
News and Trends 15 Jul 2022
Triastek forms pact with Eli Lilly to 3D print tablets for oral drug delivery
A new research collaboration between Triastek, Inc. and Eli Lilly and Company will leverage 3D printing technology to achieve precise…
